Abstract：This study reports a boy with psychomotor retardation and epilepsy due to maternal phenylketonuria (PKU). The boy was admitted at the age of 20 months because of psychomotor retardation and epilepsy. He had seizures from the age of 1 year. His development quotient was 43. He presented with microcephaly, normal skin and hair color. Brain MRI scan showed mild cerebral white matter demyelination, broadening bilateral lateral ventricle and foramen magnum stricture. Chromosome karyotype, urine organic acids, blood amino acids and acylcarnitines were normal. His mother had mental retardation from her childhood. She presented with learning difficulties and yellow hair. Her premarriage health examinations were normal. She married a healthy man at age of 26 years. When she visited us at 28 years old, PKU was found by markedly elevated blood phenylalanine (916.54 μmol/L vs normal range 20-120 μmol/L). On her phenylalanine hydroxylase (PAH) gene, a homozygous mutations c.611A>G (p.Y204C) was identified, which confirmed the diagnosis of PAH-deficient PKU. Her child carries a heterozygous mutation c.611A>G with normal blood phenylalanine. Her husband had no any mutation on PAH. It is concluded that family investigation is very important for the etiological diagnosis of the children with mental retardation and epilepsy. Carefully clinical and metabolic survey should be performed for the parents with mental problems to identify parental diseases-associated child brain damage, such as maternal PKU.
Zhu T, Qin S, Ye J, et al. Mutational spectrum of phenylketonuria in the Chinese Han population: a novel insight into the geographic distribution of the common mutations[J]. Pediatr Res, 2010, 67(3): 280-285.
[4]
Blau N, Hennermann JB, Langenbeck U, et al. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies[J]. Mol Genet Metab, 2011, 104 (Suppl): S2-S9.
[5]
Donlon J, Levy H, Scriver CR. Hyperphenylalaninemia: Phenylalanine hydroxylase deficiency[M]//Valle D, Beaudet AL, Vogelstein B, et al. The Metabolic and Molecular Bases of Inherited Disease. 8. Vol. 77. New York: McGraw-Hill, 2001: 1-150.
[6]
DiLella AG, Kwok SC, Ledley FD, et al. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene[J]. Biochemistry, 1986, 25 (4): 743-749.
Trefz F, Maillot F, Motzfeldt K, et al. Adult phenylketonuria outcome and management[J]. Mol Genet Metab, 2011, 104 (Suppl): S26-S30.
[14]
Waisbren SE, Doherty LB, Bailey IV, et al. The New England Maternal PKU Project: identification of at-risk women[J]. Am J Public Health, 1988, 78(7): 789-792.
[15]
Koch R, Trefz F, Waisbren S. Psychosocial issues and outcomes in maternal PKU[J]. Mol Genet Metab, 2010, 99 (Suppl 1): S68-S74.
Wendel U, Ozalp I, Langenbeck U, et al. Phenylketonuria in Turkey: experience with an enzymatic colorimetric test for measurement of serum phenylalanine[J]. Inher Metab Dis, 1990, 13(3): 295-297.
[20]
Blau N, Bélanger-Quintana A, Demirkol M, et al. Management of phenylketonuria in Europe: survey results from 19 countries[J]. Mol Genet Metab, 2010, 99(2): 109-115.
[21]
Hanley WB. Adult phenylketonuria[J]. Am J Med, 2004, 117(8): 590-595.
[22]
ten Hoedt AE, de Sonneville LM, Francois B, et al. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial[J]. J Inherit Metab Dis, 2011, 34(1): 165-171.
[23]
Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies[J]. N Engl J Med, 1980, 303(21): 1202-1208.
Koch R, Hanley W, Levy H, et al. Maternal phenylketonuria: an international study[J]. Mol Genet Metab, 2000, 71(1-2): 233-239.
[26]
Maillot F, Cook P, Lilburn M, et al. A practical approach to maternal phenylketonuria management[J]. J Inherit Metab Dis, 2007, 30(2): 198-201.
[27]
Levy HL. Historical background for the maternal PKU syndrome[J]. Pediatrics, 2003, 112(6 Pt 2): 1516-1518.
[28]
Waisbren SE, Chang P, Levy HL, et al. Neonatal neurological assessment of offspring in maternal phenylketonuria[J]. J Inherit Metab Dis, 1998, 21(1): 39-48.
Koch R, Moseley K, Guttler F. Tetrahydrobiopterin and maternal PKU[J]. Mol Genet Metab, 2005, 86(Suppl 1): S139-S141.
[31]
Feillet F, Muntau AC, Debray FG, et al. Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases[J]. J Inherit Metab Dis, 2014, 37(5): 753-762.
[32]
American Academy of Pediatrics Committee on Genetics. Maternal phenylketonuria[J]. Pediatrics, 1991, 88(6): 1284-1285.
[33]
Hanley WB. Finding the fertile woman with phenylketonuria[J]. Eur J Obstet Gynecol Reprod Biol, 2008, 137 (2): 131-135.
